Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter, Open-Label, Randomized Controlled Trial of Warfarin and Edoxaban Tosilate Hydrate for the Treatment of Deep Vein Thrombosis in Persons with Severe Motor Intellectual Disabilities.
Ohmori H, Nakamura M, Kada A, Saito AM, Sanayama Y, Shinagawa T, Fujita H, Wakisaka A, Maruhashi K, Okumura A, Takizawa N, Murata H, Inoue M, Kaneko H, Taniguchi H, Kawasaki M, Sano N, Akaboshi S, Tanuma N, Sone S, Kumode M, Takechi T, Koretsune Y, Sumimoto R, Miyanomae T. Ohmori H, et al. Among authors: saito am. Kurume Med J. 2018 Dec 21;65(1):11-16. doi: 10.2739/kurumemedj.MS651003. Epub 2018 Aug 30. Kurume Med J. 2018. PMID: 30158356 Free article.
Replacement of warfarin with a novel oral anticoagulant in endoscopic mucosal resection: a multicentre, open-label, randomised controlled trial.
Yamada T, Kada A, Uraoka T, Kuwai T, Watanabe N, Sasaki Y, Mabe K, Takahashi Y, Kagaya T, Kimura T, Hamada H, Saito AM, Harada N. Yamada T, et al. Among authors: saito am. BMJ Open Gastroenterol. 2017 Sep 15;4(1):e000152. doi: 10.1136/bmjgast-2017-000152. eCollection 2017. BMJ Open Gastroenterol. 2017. PMID: 29018538 Free PMC article.
Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol.
Sekimizu M, Iguchi A, Mori T, Koga Y, Kada A, Saito AM, Horibe K. Sekimizu M, et al. Among authors: saito am. BMC Cancer. 2018 Feb 1;18(1):122. doi: 10.1186/s12885-018-4042-1. BMC Cancer. 2018. PMID: 29390984 Free PMC article. Clinical Trial.
A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial.
Sekimizu M, Osumi T, Fukano R, Koga Y, Kada A, Saito AM, Mori T. Sekimizu M, et al. Among authors: saito am. Acta Med Okayama. 2018 Aug;72(4):431-436. doi: 10.18926/AMO/56184. Acta Med Okayama. 2018. PMID: 30140094 Free article.
Multicentre, open-label, randomised controlled clinical trial to assess the efficacy and safety of appropriate target values for lipid management in patients who have mild-to-moderate stenotic lesions with high-risk plaques in coronary arteries: study protocol.
Matsuda M, Kada A, Saito AM, Hasegawa K. Matsuda M, et al. Among authors: saito am. BMJ Open. 2019 Jan 25;9(1):e022843. doi: 10.1136/bmjopen-2018-022843. BMJ Open. 2019. PMID: 30782687 Free PMC article.
142 results